INTERNATIONAL PATENT: REST THERAPEUTICS FILES APPLICATION FOR "FLUOROETHYLNORMEMANTINE DERIVATIVES FOR USE THEREOF AS A DRUG"

GENEVA, Jan. 5 -- REST THERAPEUTICS (73 rue de Vaugirard75006 Paris) filed a patent application (PCT/EP2025/068173) for "FLUOROETHYLNORMEMANTINE DERIVATIVES FOR USE THEREOF AS A DRUG" on Jun 26, 2025. With publication no. WO/2026/003229, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RUBINSTENN, Gilles (c/o ReST Therapeutics73 rue de Vaugirard75006 Paris), FREYSSIN, Aline (c/o ReST Therapeutics73 rue de Vaugirard75006 Paris)

Abstract: The invention relates to a compound selected from 3-(3-fluoropropyl) adamantan-1-amine...